TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04334122

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Instrument-assisted soft tisue mobilization
Description: All patients in the experimental group were given a traditional physiotherapy program applied in lumbar disc herniation for 4 weeks (20 sessions) and 5 days a week.~In addition to the traditional physiotherapy program, the patients in the experimental group were subjected to tool-assisted soft tissue mobilization 3 times a week (12 sessions with 1 day interval).~All evaluations were repeated to all patients in the experimental and control groups after four weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional physiotherapy
Description: All patients in the control group were given a traditional physiotherapy program applied in lumbar disc herniation for 4 weeks (20 sessions) and 5 days a week.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional physiotherapy
Description: All patients in the control group were given a traditional physiotherapy program applied in lumbar disc herniation for 4 weeks (20 sessions) and 5 days a week.
Study: NCT04540172

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music Therapy
Description: Mahur tune, one of the nonverbal instruments of the Traditional Turkish Music Authorities, was selected for the study with the opinion of a music therapy specialist.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation Exercise
Description: In this study, the steps of applying progressive muscle relaxation exercise were created with the guidance of the Relaxation Exercises  materials of the Turkish Psychological Association.
Study: NCT00384813

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Project ASPIRE Home-Based Family Intervention
Description: Home-based psychoeducational family intervention jointly conducted by psychology postdoctoral fellow and respiratory therapist over 4 months

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Project ASPIRE Enhanced Treatment As Usual
Description: Psychoeducational family intervention addressing the written asthma action plan during a single home visit, conducted by a respiratory therapist
Study: NCT01764607

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sirolimus
Description: Patients randomized to this arm of the study will receive sirolimus from the time of randomization at least until 5 weeks or the removal of the skin tumor. Nephrology will determine/manage the immunosuppressant therapy.
Study: NCT03622242

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Wavelet index
Description: In wavelet index monitor, monitor patients' wavelet index based on electroencephalography as an indicator of depth of anesthesia and adjust infusion rate of propofol according to wavelet index
Study: NCT02273349

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lung Volume Reduction Coil (PneumrX Inc.)
Description: Endoscopic Lung Volume Reduction
Study: NCT01536522

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Nutritional approach for asthma
Description: participants will be provided a medium chain triglyceride supplement or placebo

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Nutritional approach for asthma
Description: participants will be provided a medium chain triglyceride supplement or placebo

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Low Caloric Shake
Description: participants will be provided a low caloric dietary shake

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: whole lung allergen challenge
Description: inhalation of allergens by allergic patients with or without asthma, will be used to define mechanisms underlying the development of airway inflammation
Study: NCT01975129

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vagitocin
Study: NCT02570399

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Oligometastatic patients with abdominal-pelvic lymph nodes
Description: Hypofractionated ablative radiation therapy for oligometastatic patients with lymph node metastases
Study: NCT02003248

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial magnetic resonance guided focused ultrasound pallidotomy
Description: Focused ultrasound is an attractive method for non-invasive thermal ablation of soft tissue, including functional brain targets. Treatment begins by acquiring a series of MR images of the target organ. The physician then identifies a target volume in the MR images, and delineates the treatment contours on the images. Therapy planning software calculates the parameters required to effectively treat the defined target volume. During the treatment, an ultrasound transducer generates a point of focused ultrasound energy, called a sonication. The sonication raises the tissue temperature within a well-defined region, enabling neurophysiological assessment in the low range, and thermal coagulation at higher ranges. MR images acquired during sonication provide a quantitative, real-time temperature map of the target area to confirm the location of the sonication and the size of the affected region.
Study: NCT01151501

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: noninvasive positive pressure ventilation
Description: Patients in whom the spontaneous breathing trial fail and in whom exclusion criteria are not present during this period were randomly allocated. Patients who are randomized to NPPV goup will be extubated and non-invasive ventilation (BiPAP Vision, Respironics Inc., Murrysville，Pennsylvania) will be delivered immediately after extubation using spontaneous/timed (S/T) mode. Expiratory positive airways pressure (PEEP) was initially set at 4 cmH2O and gradually increased to 6-8 cmH2O or more；and fraction of inspired oxygen (FiO2) was set to achieve pulse oximeter oxygen saturation (SpO2) \>92% in cooperation with PEEP. On condition that tidal volume is no less than 6ml/kg，continuous positive airway pressure (CPAP) is permitted to apply，in which the adjusting procedures of CPAP and FiO2 is similar with PEEP and FiO2 in S/T mode. NPPV is terminated When patients can spontaneously breath oxygen provided by a Venturi device at FiO2≤0.35 for more than 24 hours with SpO2\>92%.
Study: NCT01068418

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin D (cholecalciferol)
Description: cholecalciferol 15,000 IU daily for 30 days
Study: NCT04575415

Intervention type: DRUG
Intervention: Bevacizumab
Description: Bevacizumab 15mg/kg or clinical routine dose by intravenous drip infusion on day 1 of a 21-day cycle

Intervention type: DRUG
Intervention: Bevacizumab
Description: Bevacizumab 15mg/kg or clinical routine dose by intravenous drip infusion on day 1 of a 21-day cycle

Intervention type: DRUG
Intervention: Bevacizumab
Description: Bevacizumab 15mg/kg or clinical routine dose by intravenous drip infusion on day 1 of a 21-day cycle

Intervention type: DRUG
Intervention: Erlotinib
Description: Erlotinib 150mg, orally once a day

Intervention type: DRUG
Intervention: Gefitinib
Description: Gefitinib 250mg, orally once a day
Study: NCT03622242

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Wavelet index
Description: In wavelet index monitor, monitor patients' wavelet index based on electroencephalography as an indicator of depth of anesthesia and adjust infusion rate of propofol according to wavelet index
Study: NCT03321175

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: subcutaneous saline irrigation
Description: 200 cc saline irrigation
Study: NCT01648075

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Experimental: Probiotic enriched milk
Description: Milk will be enriched with lactobacillus rhamnosus for the experimental group.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Experimental: Probiotic enriched milk
Description: Milk will be enriched with lactobacillus rhamnosus for the experimental group.
Study: NCT03385109

Intervention type: DEVICE
Intervention: Surgery
Description: Patients are approached surgically with the Senhance Surgical System
Study: NCT02855892

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GV1001

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GV1001

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GV1001
Study: NCT05340283

Intervention type: PROCEDURE
Intervention: physiotherapy
Description: Patients received physiotherapy treatment at home for a certain period of time. Data were collected on the assessments made at the beginning and at the end of the physiotherapy treatment.
Study: NCT03015415

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Elbow Open Arthrolyses
Description: Elbow arthrolysis by posterior access

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Non-surgical intervention
Description: Rehabilitation with splinting protocols
Study: NCT02463292

Intervention type: OTHER
Intervention: no intervention
Description: no intervention

Intervention type: OTHER
Intervention: no intervention
Description: no intervention
Study: NCT04203225

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: LET Lidocaine (4%), Epinephrine (0.1%), and Tetracaine (0.5%) topical gel
Description: Topical anesthetic

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LET Lidocaine (4%), Epinephrine (0.1%), and Tetracaine (0.5%) topical gel
Description: Topical anesthetic
Study: NCT01529853

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SAR156597
Description: Pharmaceutical form: solution~Route of administration: subcutaneous

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SAR156597
Description: Pharmaceutical form: solution~Route of administration: subcutaneous

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SAR156597
Description: Pharmaceutical form: solution~Route of administration: subcutaneous
Study: NCT04575415

Intervention type: DRUG
Intervention: Icotinib
Description: Icotinib 125mg three times a day

Intervention type: DRUG
Intervention: Afatinib
Description: Afatinib 40 mg or clinical routine dose once daily

Intervention type: DRUG
Intervention: Dacomitinib
Description: Dacomitinib 45mg or clinical routine dose once daily

Intervention type: DRUG
Intervention: Osimertinib
Description: Osimertinib 80 mg once daily
Study: NCT00029159

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: estrogen
Description: Participants were started on ethinyl estradiol at a daily dose of 50ng/kg at the beginning of the 3rd year of the study. The estrogen was continued until study end.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: estrogen
Description: Participants were started on ethinyl estradiol at a daily dose of 50ng/kg at the beginning of the 3rd year of the study. The estrogen was continued until study end.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: androgen
Description: Oxandrolone or placebo capsule, .06mg/kg/day, orally, for 2 years

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: an inactive substance
Study: NCT01113073

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ventilatory protocol
Description: Ventilatory protocol for short period with four different tidal volumes (12 min)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Elastic band
Description: Placement of an elastic band around thorax to reduce thorax compliance

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: passive leg raising test
Description: performing the passive leg raising test
Study: NCT01079572

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: in-person
Description: Follow-up appointments will be completed in-person as per usual

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: web-based
Description: Patients who are at least 2 years following knee or hip replacement will complete a questionnaire online and routine x-rays at a PACS enabled imaging center. The patient's surgeon will receive an email from the database summarizing the patient's responses to key questions and will review the x-rays. The surgeon will determine whether the patient needs to be seen in-person.
Study: NCT00273182

Intervention type: DEVICE
Intervention: InSync Model 8040
Description: Subjects with sucessful implants of InSync Model 8040.

Intervention type: DEVICE
Intervention: InSync III Model 8042
Description: Subjects with successful implants of InSync III Model 8042
Study: NCT03257540

Intervention type: DEVICE
Intervention: Small Bone Intramedullary Nail
Description: Patients undergoing a Lapidus Arthrodesis procedure for hallux valgus correction who are receiving a Phantom Small Bone Intramedullary nail will begin weight-bearing at 2 weeks and follow a pre-determined post-operative protocol.
Study: NCT03968458

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CON
Description: . Control condition without exercise / rest condition. The adolescents will be asked to remain quiet and at rest during the morning and will receive an ad libitum meal at lunch and dinner times. Their food reward will be assessed before and after lunch. Their appetite feelings will be assessed at regular intervals.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EX-30
Description: Condition with an acute exercise set 30 minutes before lunch The adolescents will be asked to complete a 30 minutes exercise set at 65% of their capacities (cycling), 30 minutes before lunch. Lunch will be served ad libitum as well as diner. Their food reward will be assessed before and after lunch. Their appetite feelings will be assessed at regular intervals.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EX-90
Description: condition with an acute exercise set 90 minutes before lunch. The adolescents will be asked to complete a 30 minutes exercise set at 65% of their capacities (cycling), 30 minutes before lunch. Lunch will be served ad libitum as well as diner. Their food reward will be assessed before and after lunch. Their appetite feelings will be assessed at regular intervals.
Study: NCT01739530

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Repaircell
Description: allogenic differentiated adipocyte
Study: NCT03009097

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: DFDBA
Description: 13 intrabony defects in chronic periodontitis patients were treated with allograft (DFDBA)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: DFDBA with atorvastatin
Description: 13 intrabony defects in chronic periodontitis patients were treated with allograft (DFDBA) in combination with atorvastatin gel
Study: NCT03075644

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: somapacitan
Description: Once weekly subcutaneous injections (s.c., under the skin)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Norditropin
Description: Daily subcutaneous injections (s.c., under the skin)
Study: NCT00696956

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Balloon angioplasty (uncoated conventional balloon)
Description: endovascular therapy

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Balloon angioplasty (conventional but coated with 3 µg/mm2 paclitaxel)
Description: endovascular therapy
Study: NCT02957890

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Inactivated influenza vaccine (NH formulation)
Description: Round 1 (November): 0.5mL FluQuadri®, Sanofi Pasteur, containing 60μg antigen - 15μg for each influenza strain included - with strains recommended by the WHO for the northern hemisphere formulation

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Inactivated influenza vaccine (NH formulation)
Description: Round 1 (November): 0.5mL FluQuadri®, Sanofi Pasteur, containing 60μg antigen - 15μg for each influenza strain included - with strains recommended by the WHO for the northern hemisphere formulation

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Inactivated influenza vaccine (SH formulation)
Description: Round 2 (May): 0.5mL Vaxigrip®, Sanofi Pasteur, containing 45μg antigen - 15μg for each influenza strain included - with strains recommended by the WHO for the southern hemisphere formulation

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Round 2 (May): 0.5mL normal saline
Study: NCT03524703

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: chewing gum
Description: Chewing gum four times per day for 5 days, 15 minutes each time.
Study: NCT04460664

Intervention type: DIAGNOSTIC_TEST
Intervention: Quantra System
Description: Diagnostic device to monitor coagulation properties of a whole blood sample at the point-of-care.

Intervention type: DIAGNOSTIC_TEST
Intervention: Quantra System
Description: Diagnostic device to monitor coagulation properties of a whole blood sample at the point-of-care.
Study: NCT04359368

Intervention type: OTHER
Intervention: collection of patient data
Description: Data collection (history, clinical presentation, medication, complications, laboratory testing) will be performed from patient records stored in the protected electronic patient system ISMed (Integrated System for Medical Diagnostic) of patients with HSRs to NDIPs.
Study: NCT01559311

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CRT-P OFF
Description: CRT Pacemaker

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CRT-P ON
Description: CRT Pacemaker

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: DDDR
Description: Dual-chamber, rate-modulated pacemaker
Study: NCT03240627

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LH-8
Description: LH-8 cutaneous solution

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo cutaneous solution
Study: NCT00733343

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Europe: AutoSet CS (USA: VPAP Adapt SV)
Description: At least 3 hours average daily usage time
Study: NCT02423941

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Retrogade reperfusion
Description: Retrogade caval reperfusion of the donor liver during the transplant procedure with consequent arterial reperfusion.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Antegrade reperfusion
Description: Antegrade conventional portal reperfusion of the donor liver during the transplant procedure with consequent arterial reperfusion.
Study: NCT04352140

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tetragraph
Description: FDA approved neuromuscular transmission monitor capable of measuring the depth of neuromuscular block in anesthetized patients who received neuromuscular blocking agents. TetraGraph uses EMG to measure the muscle action potentials that are generated in response to electrical neurostimulation via skin electrodes.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tetragraph
Description: FDA approved neuromuscular transmission monitor capable of measuring the depth of neuromuscular block in anesthetized patients who received neuromuscular blocking agents. TetraGraph uses EMG to measure the muscle action potentials that are generated in response to electrical neurostimulation via skin electrodes.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ToFscan
Description: ToFscan is a nerve stimulator module used for the measurement of neuromuscular transmission via accelerometry. ToFscan was developed by Drager Technologies, Canada, and it uses a three-dimensional piezoelectric sensor that attaches to the thumb via a hand adapter to measure acceleration in multiple planes (Murphy et al, 2018). Following simultaneous ulnar nerve stimulation on each arm, the response of the adductor pollicis will be measured

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ToFscan
Description: ToFscan is a nerve stimulator module used for the measurement of neuromuscular transmission via accelerometry. ToFscan was developed by Drager Technologies, Canada, and it uses a three-dimensional piezoelectric sensor that attaches to the thumb via a hand adapter to measure acceleration in multiple planes (Murphy et al, 2018). Following simultaneous ulnar nerve stimulation on each arm, the response of the adductor pollicis will be measured
Study: NCT03132948

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Activity
Description: Nintendo WII fit console, Xbox console, sport activities (soccer, basketball, yoga, walking and other physical games)
Study: NCT03078946

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine Hydrochloride
Description: 30 patients received a loading dose of 1 μg/kg dexmedetomidine (Precedex; Hospira, Precedex 200 mcg/2 ml, Hospira. Inc, Lake Forest, USA) diluted in 100 ml 0.9% saline infused over 10 min immediately postoperative, followed by continuous infusion of 0.2- 0.7 μg/kg/h

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Morphine and Midazolam
Description: 30 patients received morphine in a dose of 10-50μg/ kg/hr as an analgesic (Morphine Sulphate ampoule; 10 mg/ 1ml, Misr Co.- Egypt) with midazolam in a dose of 0.05mg/kg up to 0.2 mg/kg (Dormicum; Roche; USA; ampoule containing 15 mg/3 ml mixed in sugar-free apple juice limiting the total volume mixed with a double volume of apple juice) repeated as needed.
Study: NCT03791658

Intervention type: OTHER
Group type: OTHER
Intervention: The 12-question TAI
Description: The 12-question TAI (Test for the Adherence to Inhalers) yields a score indicating level of adherence (high, intermediate or poor). The TAI also provides some indication about the possible mechanisms of non-adherence (sporadic, deliberate or unconscious).

Intervention type: OTHER
Group type: OTHER
Intervention: The 12-question TAI
Description: The 12-question TAI (Test for the Adherence to Inhalers) yields a score indicating level of adherence (high, intermediate or poor). The TAI also provides some indication about the possible mechanisms of non-adherence (sporadic, deliberate or unconscious).

Intervention type: OTHER
Group type: OTHER
Intervention: Information from patients file
Description: Depending on which arm or group specific information will be gathered from the patients file after informed consent.

Intervention type: OTHER
Group type: OTHER
Intervention: Information from patients file
Description: Depending on which arm or group specific information will be gathered from the patients file after informed consent.

Intervention type: OTHER
Group type: OTHER
Intervention: The Asthma Control Test (ACT)
Description: An international validated questionnaire on the symptoms an asthmatic experiences and the disease control in the patient. Only for the Asthmatics arm of the study

Intervention type: OTHER
Group type: OTHER
Intervention: The COPD Assessment Test (CAT)
Description: An international validated questionnaire on the symptoms a COPD-patient experiences and the disease control in the patient. Only for the COPD arm of the study